Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kern

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysisOzgur Tunceli, Setareh A Williams, David M Kern, et al.
Clinical Therapeutics|June 15, 2019
Incidence and Prevalence of Microvascular and Macrovascular Diseases and All-cause Mortality in Type 2 Diabetes Mellitus: A 10-year Study in a US Commercially Insured and Medicare Advantage PopulationJay Visaria, Neeraj N Iyer, Amit Raval, et al.
Journal of Managed Care & Specialty Pharmacy|May 1, 2019
Health Plan Enrollment and Disenrollment of Individuals With and Without Established Chronic Disease in a U.S. Commercially Insured and Medicare Advantage PopulationHaechung Chung, Gaurav Deshpande, Julia Zolotarjova, et al.
Health and Quality of Life Outcomes|December 29, 2012
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal studyJudith J Stephenson, David M Kern, Sonalee S Agarwal, et al.
Respiratory Research|April 23, 2015
Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database studyDavid M Kern, Jill Davis, Setareh A Williams, et al.
JMIR Research Protocols|October 13, 2017
Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study ProtocolLisa M Hess, David M Kern, Gebra Cuyun Carter, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 30, 2014
A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary diseaseDavid M Kern, Setareh A Williams, Ozgur Tunceli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 1, 2015
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD populationDavid M Kern, Jill Davis, Setareh A Williams, et al.
Psychiatric Research and Clinical Practice|September 14, 2022
Revealing Unknown Benefits of Existing Medications to Aid the Discovery of New Treatments for Post-Traumatic Stress DisorderDavid M Kern, Rachel E Teneralli, Christopher M Flores, et al.
Journal of Pain Research|April 21, 2020
The Association Between Doctor and Pharmacy Shopping and Self-Reported Misuse and Abuse of Prescription Opioids: A Survey StudyJudith J Stephenson, M Soledad Cepeda, Jie Zhang, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysisOzgur Tunceli, Setareh A Williams, David M Kern, et al.
Clinical Therapeutics|June 15, 2019
Incidence and Prevalence of Microvascular and Macrovascular Diseases and All-cause Mortality in Type 2 Diabetes Mellitus: A 10-year Study in a US Commercially Insured and Medicare Advantage PopulationJay Visaria, Neeraj N Iyer, Amit Raval, et al.
Journal of Managed Care & Specialty Pharmacy|May 1, 2019
Health Plan Enrollment and Disenrollment of Individuals With and Without Established Chronic Disease in a U.S. Commercially Insured and Medicare Advantage PopulationHaechung Chung, Gaurav Deshpande, Julia Zolotarjova, et al.
Health and Quality of Life Outcomes|December 29, 2012
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal studyJudith J Stephenson, David M Kern, Sonalee S Agarwal, et al.
Respiratory Research|April 23, 2015
Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database studyDavid M Kern, Jill Davis, Setareh A Williams, et al.
JMIR Research Protocols|October 13, 2017
Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study ProtocolLisa M Hess, David M Kern, Gebra Cuyun Carter, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 30, 2014
A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary diseaseDavid M Kern, Setareh A Williams, Ozgur Tunceli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 1, 2015
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD populationDavid M Kern, Jill Davis, Setareh A Williams, et al.
Psychiatric Research and Clinical Practice|September 14, 2022
Revealing Unknown Benefits of Existing Medications to Aid the Discovery of New Treatments for Post-Traumatic Stress DisorderDavid M Kern, Rachel E Teneralli, Christopher M Flores, et al.
Journal of Pain Research|April 21, 2020
The Association Between Doctor and Pharmacy Shopping and Self-Reported Misuse and Abuse of Prescription Opioids: A Survey StudyJudith J Stephenson, M Soledad Cepeda, Jie Zhang, et al.
Pageof 10